Artificial Intelligence Biotech Data Center Development 
Crunchbase News
MAY 2, 2024
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generative AI markets.
Crunchbase News
APRIL 19, 2024
Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. That’s still a lot of cash, but clearly round size trended down.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Crunchbase News
MARCH 29, 2024
While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Earlier in March, shares of Astera Labs — a developer of data center connectivity technology with use cases in generative AI — soared after its initial public offering on the Nasdaq.
CIO
SEPTEMBER 18, 2023
The latest piece in her reinvention story is Synchrony’s new Tech Apprenticeship for Artificial Intelligence, a full-time, 12-month program that balances on-the-job learning with instructor-led training, providing Chavarin with a pathway into one of the most coveted technology spaces despite her very nontraditional IT background.
TechCrunch
SEPTEMBER 8, 2022
Data needs to be stored somewhere. However, data storage costs keep growing, and the data people keep producing and consuming can’t keep up with the available storage. According to Internet Data Center (IDC) , global data is projected to increase to 175 zettabytes in 2025, up from 33 zettabytes in 2018.
Crunchbase News
DECEMBER 21, 2023
Artificial intelligence was big in 2023 — and that could be the understatement of the year. As part of the deal, Anthropic will now use Amazon Web Services data centers, as well as AWS Trainium and Inferentia chips to build, train and deploy its models. It even has invested in a handful of biotech companies using AI.
TechCrunch
NOVEMBER 9, 2021
Khosla said that a good analogy was biotech/pharma investing, where it takes 10-15 years from concept to a drug approved on market. .” To summarize the scale of efforts needed, Bill Gross, the founder of Idealab , Heliogen and Energy Vault , said , “We need thousands of shots on goal to do it, and entrepreneurship is the answer.”
Expert insights. Personalized for you.
115 
Let's personalize your content